1832 Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
1832 Asset Management's RMD Position: Q3 2026 in Review
1832 Asset Management reduced its ResMed (RMD) stake by 1.4% in Q3 2026, selling an estimated $82.9K and leaving 26,477 shares worth $5.85M. The position accounts for ﹤0.01% of the portfolio, ranked #380.
1832 Asset Management first reported a position in RMD in Q3 2021 and has held it in 12 quarters since. The position peaked at $10.3M in Q3 2025. 884 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- 1832 Asset Management held 26,477 shares of ResMed worth $5.85M as of Q3 2026.
- 1832 Asset Management sold 380 ResMed shares in Q3 2026, an estimated $82.9K.
- ResMed made up ﹤0.01% of 1832 Asset Management's portfolio in Q3 2026, its #380 holding.
- 1832 Asset Management first reported a position in ResMed in Q3 2021 and has held it in 12 quarters since.
- 1832 Asset Management's ResMed position peaked at $10.3M in Q3 2025.
- 884 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on 1832 Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.